Septic Complications in Arthroplasty

Chapter

Abstract

In the present chapter incidence of revision in primary and revision total hip and knee arthroplasty is presented mainly based on registry data. The information is then discussed separately for primary and revision arthroplasty focusing on the septic reasons for revision. Influence of registries on improvement of joint arthroplasty outcomes is discussed as well.

Keywords

Complications Hip Knee Infection 

References

  1. 1.
    Wilson MG, et al. Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am. 1990;72(6):878–83.PubMedGoogle Scholar
  2. 2.
    Berbari EF, et al. Risk factors for prosthetic joint infection: case control study. Clin Infect Dis. 1998;27(5):1247–54.PubMedCrossRefGoogle Scholar
  3. 3.
    Peersman G, et al. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res. 2001;392:15–23.PubMedCrossRefGoogle Scholar
  4. 4.
    Chiu FY, et al. Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus. A prospective, randomized study. J Bone Joint Surg Br. 2001;83(5):691–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Meding JB, et al. Total knee replacement in patients with diabetes mellitus. Clin Orthop Relat Res. 2003;416:208–16.PubMedCrossRefGoogle Scholar
  6. 6.
    Winiarsky R, et al. Total knee arthroplasty in morbidly obese patients. J Bone Joint Surg Am. 1998;80(12):1770–4.PubMedGoogle Scholar
  7. 7.
    Amin AK, et al. Does obesity influence the clinical outcome at 5 years following total knee replacement for osteoarthritis? J Bone Joint Surg Br. 2006;88(3):335–40.PubMedCrossRefGoogle Scholar
  8. 8.
    Krushell RJ, et al. Primary total knee arthroplasty in morbidly obese patients: a 5 to 14 year follow-up study. J Arthroplasty. 2007;22(6 Supp 2):77–80.PubMedCrossRefGoogle Scholar
  9. 9.
    Blom AW, et al. Infection after total knee arthroplasty. J Bone Joint Surg Br. 2004;86(5):688–91.PubMedCrossRefGoogle Scholar
  10. 10.
    Hanssen AD, Rand JA. Evaluation and treatment of infection at site of total hip and knee arthroplasty. Instr Course Lect. 1999;48:111–22.PubMedGoogle Scholar
  11. 11.
    Pulido L, et al. Periprosthetic joint infection: the incidence, timing and predisposing factors. Clin Orthop Relat Res. 2008;446(7):1710–5.CrossRefGoogle Scholar
  12. 12.
    Lie SA, et al. Failure rates for 4762 revision total hip arthroplasties in the Norwegian Arthroplasty Register. J Bone Joint Surg Br. 2004;86(4):504–9.PubMedGoogle Scholar
  13. 13.
    Espehaug B, et al. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian Arthroplasty Register, 1987–1995. J Bone Joint Surg Br. 1997;79(4):590–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Senthi S, et al. Infection in total hip replacement: meta-analysis. Int Orthop (SICOT). 2011;35:253–60.CrossRefGoogle Scholar
  15. 15.
    Ganse B, et al. Two-stage hip revision arthroplasty: the role of the excision arthroplasty. Eur J Orthop Surg Traumatol. 2008;18(3):223–8.CrossRefGoogle Scholar
  16. 16.
    Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358(9276):135–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2012

Authors and Affiliations

  1. 1.Department of Orthopaedic SurgeryInnsbruck Medical UniversityInnsbruckAustria

Personalised recommendations